Impax Laboratories Inc (NASDAQ:IPXL)

46.60
BATS BZX Real-Time Price
As of 10:16am ET
 +0.86 / +1.88%
Today’s Change
22.12
Today|||52-Week Range
47.70
+47.10%
Year-to-Date

Today’s Trading

Previous close45.74
Today’s open45.84
Day’s range45.84 - 46.81
Volume40,704
Average volume (3 months)675,026
Market cap$3.3B
Dividend yield--
Data as of 10:02am ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)-44.90%
Earnings growth (this year)+13.19%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+16.53%
P/E ratio57.3
Price/Sales3.62
Price/Book3.67

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...+1.23+3.17%
ACADACADIA Pharmaceutica...+0.51+1.60%
HZNPHorizon Pharma PLC+3.37+15.45%
WXWuxi Pharmatech Caym...+0.20+0.53%
Data as of 10:17am ET, 03/30/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)$0.16
Annual revenue (last year)$596.0M
Annual profit (last year)$57.4M
Net profit margin9.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
George Frederick Wilkinson
Chief Financial Officer &
Senior Vice President
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account